Utah Medical Products Inc. has repurchased 132,979 shares of its common stock at $1.69 per share, an aggregate price of approximately $225,000, from Baxter Healthcare Corp. - part of a Utah Medical plan to reduce its 7.4 million shares currently outstanding.

This action was in accordance with the terms of a contract between Utah Medical Products and Baxter Healthcare signed in December 1987.Projected value of the six-year contract for Baxter to purchase current products, as well as products to be developed, is approximately $40 million.

Utah Medical earlier announced unaudited record-breaking sales for 1988 of $13.02 million and earnings of $1.40 million, representing an increase over 1987 of 72 percent in sales and 107 percent in earnings.